BDBM38839 1-[2-[2-keto-3-(4-methylbenzyl)imidazolidin-1-yl]acetyl]isonipecotamide::1-[2-[3-[(4-methylphenyl)methyl]-2-oxidanylidene-imidazolidin-1-yl]ethanoyl]piperidine-4-carboxamide::1-[2-[3-[(4-methylphenyl)methyl]-2-oxo-1-imidazolidinyl]-1-oxoethyl]-4-piperidinecarboxamide::1-[2-[3-[(4-methylphenyl)methyl]-2-oxoimidazolidin-1-yl]acetyl]piperidine-4-carboxamide::MLS000120190::SMR000097107::cid_5307433

SMILES Cc1ccc(CN2CCN(CC(=O)N3CCC(CC3)C(N)=O)C2=O)cc1

InChI Key InChIKey=DWKYETZQTXNBTF-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 38839   

TargetM-phase inducer phosphatase 2(Human)
University of Pittsburgh

Curated by PubChem BioAssay
LigandPNGBDBM38839(cid_5307433 | MLS000120190 | SMR000097107 | 1-[2-[...)
Affinity DataIC50: 5.00E+4nMAssay Description:The Cdc25B Phosphatase HTS dose response confirmation has been developed to confirm actives identified in the Cdc25B HTS AID 368, screened at the Uni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2011
Entry Details
PCBioAssay